The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Inhibition of protein–protein interactions using designed molecules
Abstract
Although many cellular processes depend upon enzymatic reactions, protein-protein interactions (PPIs) mediate a large number of important regulatory pathways and thus play a central role in disease development. In order to understand and selectively inhibit cellular signalling pathways, there is a pressing need for small molecules that target PPIs, particularly in the context of pharmaceutical development. This tutorial review will introduce the relevance of PPIs to chemical biology and highlight the key challenges in designing inhibitors. Some of the successes using conventional approaches to the identification of small-molecule PPI inhibitors will be highlighted, and also the reasons why these approaches have not always proven successful. Several general approaches tailored to particular protein topologies are emerging for the design of scaffolds that inhibit PPIs-these will form the major content of this review. Finally a summary of the challenges to be faced in developing inhibitors of PPIs into drug leads and how these challenges may differ from those encountered with enzyme-like targets will be given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Gellman, S. H. (1998) · Accounts of Chemical Research · doi:10.1021/ar960298r · Cited by 2,506
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Applications of Nanoparticles in Biology
De, M., Ghosh, P. S., & Rotello, V. M. (2008) · Advanced Materials · doi:10.1002/adma.200703183 · Cited by 1,547
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease
Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,168
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
Babine, R. E., & Bender, S. L. (1997) · Chemical Reviews · doi:10.1021/cr960370z · Cited by 892
You, C.-C., Miranda, O. R., Gider, B., Ghosh, P. S., Kim, I.-B., Erdogan, B., Krovi, S. A., Bunz, U. H. F., & Rotello, V. M. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.99 · Cited by 776
Principles of Protein−Protein Interactions: What are the Preferred Ways For Proteins To Interact?
Keskin, O., Gursoy, A., Ma, B., & Nussinov, R. (2008) · Chemical Reviews · doi:10.1021/cr040409x · Cited by 697
Pelletier, H., & Kraut, J. (1992) · Science · doi:10.1126/science.1334573 · Cited by 676
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
Yin, H., & Hamilton, A. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461786 · Cited by 453
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
Grasberger, B. L., Lu, T., Schubert, C., Parks, D. J., Carver, T. E., Koblish, H. K., Cummings, M. D., LaFrance, L. V., Milkiewicz, K. L., Calvo, R. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049137g · Cited by 432
Orner, B. P., Ernst, J. T., & Hamilton, A. D. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0025548 · Cited by 320
A Calixarene with Four Peptide Loops: An Antibody Mimic for Recognition of Protein Surfaces
Hamuro, Y., Calama, M. C., Park, H. S., & Hamilton, A. D. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199726801 · Cited by 210
McMillan, K., Adler, M., Auld, D. S., Baldwin, J. J., Blasko, E., Browne, L. J., Chelsky, D., Davey, D., Dolle, R. E., Eagen, K. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1506 · Cited by 201
Short constrained peptides that inhibit HIV-1 entry
Sia, S. K., Carr, P. A., Cochran, A. G., Malashkevich, V. N., & Kim, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232566599 · Cited by 195
Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors
Fischer, N. O., McIntosh, C. M., Simard, J. M., & Rotello, V. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082644099 · Cited by 192
Inhibiting HIV Fusion with a β-Peptide Foldamer
Stephens, O. M., Kim, S., Welch, B. D., Hodsdon, M. E., Kay, M. S., & Schepartz, A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053444+ · Cited by 174
Sadowsky, J. D., Fairlie, W. D., Hadley, E. B., Lee, H.-S., Umezawa, N., Nikolovska-Coleska, Z., Wang, S., Huang, D. C. S., Tomita, Y., & Gellman, S. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0662523 · Cited by 174
Wang, D., Liao, W., & Arora, P. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501603 · Cited by 157
Vita, C., Drakopoulou, E., Vizzavona, J., Rochette, S., Martin, L., Ménèz, A., Roumestand, C., Yang, Y., Ylisastigui, L., Benjouad, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13091 · Cited by 155
Blaskovich, M. A., Lin, Q., Delarue, F. L., Sun, J., Park, H. S., Coppola, D., Hamilton, A. D., & Sebti, S. M. (2000) · Nature Biotechnology · doi:10.1038/80257 · Cited by 143
Fasan, R., Dias, R. L. A., Moehle, K., Zerbe, O., Obrecht, D., Mittl, P. R. E., Grütter, M. G., & Robinson, J. A. (2006) · ChemBioChem · doi:10.1002/cbic.200500452 · Cited by 129
Betzi, S., Restouin, A., Opi, S., Arold, S. T., Parrot, I., Guerlesquin, F., Morelli, X., & Collette, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707130104 · Cited by 129
Design and synthesis of α-helical peptides and mimetics
Garner, J., & Harding, M. M. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b710425a · Cited by 129
Protein Prosthesis: A Semisynthetic Enzyme with a β-Peptide Reverse Turn
Arnold, U., Hinderaker, M. P., Nilsson, B. L., Huck, B. R., Gellman, S. H., & Raines, R. T. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026114n · Cited by 128
Solid-Phase Syntheses of β-Turn Analogues To Mimic or Disrupt Protein−Protein Interactions
Burgess, K. (2001) · Accounts of Chemical Research · doi:10.1021/ar9901523 · Cited by 115
Design and Evolution of a Miniature Bcl-2 Binding Protein
Chin, J. W., & Schepartz, A. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20011015)40:20<3806::aid-anie3806>3.0.co;2-b · Cited by 112
Ojida, A., Inoue, M.-A., Mito-oka, Y., & Hamachi, I. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036317r · Cited by 109
A Noncovalent Approach to Antiparallel β-Sheet Formation
Zeng, H., Yang, X., Flowers, R. A. I., et al. (2002) · Journal of the American Chemical Society · doi:10.1021/ja010701b · Cited by 101
Surface Recognition of a Protein Using Designed Transition Metal Complexes
Fazal, M. A., Roy, B. C., Sun, S., Mallik, S., & Rodgers, K. R. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003193z · Cited by 98
Photocontrollable Peptide‐Based Switches Target the Anti‐Apoptotic Protein Bcl‐xL
Kneissl, S., Loveridge, E. J., Williams, C., Crump, M. P., & Allemann, R. K. (2008) · ChemBioChem · doi:10.1002/cbic.200800502 · Cited by 97
Heterocyclic α-helix mimetics for targeting protein–protein interactions
Biros, S. M., Moisan, L., Mann, E., Carella, A., Zhai, D., Reed, J. C., & REBEK, J. J. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.075 · Cited by 75
β-Peptides with improved affinity for hDM2 and hDMX
Harker, E. A., Daniels, D. S., Guarracino, D. A., & Schepartz, A. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.01.039 · Cited by 74
Selective disruption of protein aggregation by cyclodextrin dimers
Leung, D. K.-W., Yang, Z., & Breslow, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5050 · Cited by 72
α-Helix mimetics as inhibitors of protein–protein interactions
Saraogi, I., & Hamilton, A. D. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361414 · Cited by 70
Hayashida, O., Ogawa, N., & Uchiyama, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074906h · Cited by 69
Thermodynamics of p53 Binding to hdm2(1–126): Effects of Phosphorylation and p53 Peptide Length
Lai, Z., Auger, K. R., Manubay, C. M., & Copeland, R. A. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1998 · Cited by 66
Park, H. S., Lin, Q., & Hamilton, A. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082675899 · Cited by 66
Smith, A. B., Hirschmann, R. F., Pasternak, A., Yao, W., Sprengeler, P. A., Holloway, M. K., Kuo, L. C., Chen, Z., Darke, P. L., & Schleif, W. A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970195u · Cited by 63
Wei, Y., McLendon, G. L., Case, M. A., Purring-Koch, C., Yu, T., Hamilton, A. D., Lin, Q., Park, H. S., & Lee, C.-S. (2001) · Chemical Communications · doi:10.1039/b104142h · Cited by 58
Kaul, R., Deechongkit, S., & Kelly, J. W. (2002) · Journal of the American Chemical Society · doi:10.1021/ja020675x · Cited by 48
Rodriguez, J. M., Nevola, L., Ross, N. T., Lee, G., & Hamilton, A. D. (2009) · ChemBioChem · doi:10.1002/cbic.200800715 · Cited by 45
Calorimetric studies on the interaction of horse ferricytochrome c and yeast cytochrome c peroxidase
Kresheck, G. C., Vitello, L. B., & Erman, J. E. (1995) · Biochemistry · doi:10.1021/bi00026a022 · Cited by 45
Synthetic Receptors for the Differentiation of Phosphorylated Peptides with Nanomolar Affinities
Grauer, A., Riechers, A., Ritter, S., & König, B. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800432 · Cited by 36
Rajagopal, S., Meyer, S. C., Goldman, A. J., Zhou, M., & Ghosh, I. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064885b · Cited by 12
Cited by
Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications
Almanza, A., Carlesso, A., Chintha, C., Creedican, S., Doultsinos, D., Leuzzi, B., Luís, A., McCarthy, N., Montibeller, L., More, S., et al. (2019) · The FEBS Journal · doi:10.1111/febs.14608 · Cited by 1,034
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
On the binding affinity of macromolecular interactions: daring to ask why proteins interact
Kastritis, P. L., & Bonvin, A. M. J. J. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0835 · Cited by 520
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497
Peptides Containing β-Amino Acid Patterns: Challenges and Successes in Medicinal Chemistry
Cabrele, C., Martinek, T. A., Reiser, O., & Berlicki, Ł. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010896 · Cited by 368
Metadata
- Authors
- J. Wilson, A.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2009
- Volume
- 38
- Issue
- 12
- Pages
- 3289
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2105287154
- Cited by
- 262
- References
- 52
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.